Multicenter, cross-sectional study investigating the prevalence of defined Clostridium difficile infection (CDI) protective candidate components of the intestinal microbiota
- Conditions
- A04.7Enterocolitis due to Clostridium difficile
- Registration Number
- DRKS00011801
- Lead Sponsor
- MHH OE6810
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting withdrawn before recruiting started
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Inpatients with indication for the C. difficile diagnostics with positive (cases) or negative (controls) results, informed consent from patients after patient education
Exclusion Criteria
CDI or suspected CDI within 30 days prior to enrollment; diseases which prevent candidates to understand the nature and the consequences of the clinical trial; indications for protocol non-compliance
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of potential protective strains of CDI patients vs. controls<br>Identification of components of the commensal microbiota with a protective effect against C. difficile infection
- Secondary Outcome Measures
Name Time Method Compliance with microbiota results from the SPECTRUM-Study